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Abstract
Production and release of apolipoprotein (apo) E and cholesterol were highly upregulated in the astrocytes prepared by 1-week secondary
culture after 1-month primary culture of rat fetal brain cells (M/W cells) in comparison to the cells prepared by a conventional method of 1-
week primary and 1-week secondary culture (W/W cells). Both cell preparations were mostly composed of astrocytes with small population
of other glial cells, except that type-2 astrocyte-like cells accounted for 5–15% of M/W cells indicating more activated and/or matured status.
The conditioned medium of the 1-month primary culture stimulated W/W cells to increase the release of apoE and cholesterol into the
medium. The treatment of W/W cells by acidic fibroblast growth factor (aFGF) similarly upregulated biosyntheses and release of apoE and
cholesterol. The effect of the conditioned medium was completely inhibited by pretreatment with an anti-aFGF antibody. The increase of the
aFGF message was demonstrated in the brain cells after 1-month primary culture. The findings suggested that an aFGF-like trophic factor
upregulates biosynthesis and secretion of apoE-high density lipoprotein (HDL) in astrocytes probably by autocrine stimulation in this culture
system. Since this cytokine is highly expressed in the development or post-injury period of the brain, it putatively activates intercellular
cholesterol transport to support construction or recovery of the brain. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
More than 25% of total body cholesterol in human is
found in the central nervous system (CNS) and it accounts
for 10% of the brain dry mass. While extracellular choles-
terol transport is generally carried by the plasma lipoprotein
system as an important part of cholesterol homeostasis in
mammalian bodies, the cells in the CNS are segregated from
the lipoproteins in the systemic circulation by the blood
brain barrier and use their own lipoprotein system distinct
from plasma lipoproteins. Lipoproteins found in cerebrospi-
nal fluid are all high density lipoproteins (HDL) that contain
apolipoprotein(apo) E, A-I, A-IV or J [1], and are believed
to compose a specific system for regulation of cholesterol
homeostasis in the CNS.
Apo E, a glycosylated 34-kDa apolipoprotein, is a major
apolipoprotein in cerebrospinal fluid. It is synthesized and
secreted by astrocytes and microglias being complexed with
phospholipid and cholesterol as HDL particle [2–6]. Syn-
thesis of apoE by astrocytes largely depends on the stage of
cellular differentiation and many astrocytoma cells do not
synthesize apoE [7,8]. However, the mechanism is unknown
for assembly and secretion of HDL particles by astrocytes
with endogenously synthesized apoE, and an exact function
of such apoE-HDL is unclear in cholesterol homeostasis
among glias and neurons in the CNS. We have reported that
the astrocytes secrete apoE along with cellular cholesterol
and phospholipid to generate cholesterol-rich HDL while
0167-4889/02/$ - see front matter D 2002 Elsevier Science B.V. All rights reserved.
PII: S0167 -4889 (02 )00181 -7
Abbreviations: CNS, central nervous system; HDL, high density
lipoprotein; Apo, apolipoprotein; LDL, low density lipoprotein; aFGF,
acidic fibroblast growth factor; FCS, fetal calf serum; DPBS, Dulbecco’s
phosphate buffered saline; EDTA, ethylenediaminetetraacetic acid; BSA,
bovine serum albumin; HMG-CoA, hydroxymethylglutaryl-CoA; TLC,
thin layer chromatography; SDS-PAGE, polyacrylamide gel electropho-
resis; GFAP, glial fibrillary acidic protein; RT-PCR, reverse transcription-
polymerase chain reaction
* Corresponding author. Tel.: +81-52-853-8139; fax: +81-52-841-3480.
E-mail address: jitoh@med.nagoya-cu.ac.jp (J. Ito).
www.bba-direct.com
Biochimica et Biophysica Acta 1589 (2002) 261–272
cholesterol-poor HDL is generated by extracellular apoA-I
[9]. The cholesterol content in the HDL generated by
exogenous apolipoprotein is regulated by cholesterol–
sphingomyelin interaction in ‘‘raft’’ domains of the astro-
cyte plasma membrane [10].
In the CNS and in the peripheral nerve system, apoE
synthesis and secretion increase during their development or
after their injury, and apoE accumulates in the damaged
lesions [3,11–18]. Therefore, apoE has been proposed to
play a major role in construction and regeneration of the
nerve system. On the other hand, apoE4, one of the major
three apoE isoforms, has been highlighted as it associates
with Alzheimer’s disease [19–21] and with poor prognosis
after acute and chronic brain damage [22–24], though the
specific mechanism is still unclear.
Some of the ‘‘apoE receptors’’ may function to uptake
apoE-HDL so that the cholesterol-rich HDLwith apoEwould
serve as a cholesterol delivery vehicle to the cells for their
growth and regeneration. Those receptors include low density
lipoprotein (LDL) receptor [25], very low density lipoprotein
receptor [26], LDL receptor-related protein [26], or apoE
receptor 2 [27], all of which belong to the LDL-receptor
superfamily. The LDL receptor in neuron indeed seems to
mediate cholesterol uptake from apoE-containing lipoprotein
for regeneration of axons [28]. On the other hand, the large
matrix protein Reelin, which regulates neuronal migration
and positioning in the brain, binds to very low density
lipoprotein receptor and apoE receptor 2, resulting in activa-
tion of tyrosine kinases via Dab 1 linked to its cytosolic
domain and apoE receptor 2 [29,30]. Therefore, apoE may
contribute to the neuronal activities in the brain by the control
of the binding of Reelin to such apoE receptors.
The purpose of this study is to understand regulation of
the synthesis and secretion of apoE in relation to cholesterol
metabolism in astrocytes. If the upregulation of apoE-HDL
secretion is required for development of brain or recovery
from brain injury, extracellular factors may be involved in
stimulation of apoE biosynthesis and apoE-HDL generation.
In order to approach this problem, we investigated these
parameters in a developmental model of astrocytes by
employing long-term primary culture of the fetal rat brain
cells. We demonstrate that apoE synthesis, HDL secretion
and cholesterol biosynthesis were enhanced in rat astrocytes
by an acidic fibroblast growth factor (aFGF)-like trophic
factor secreted during the long-term primary culture of the
brain cells.
2. Materials and methods
2.1. Preparation of fetal rat astrocytes
Astrocytes were prepared from the cerebrum of 17-day
fetal Wistar rat according to the previous method [31,32].
After removal of the meninges, the cerebral hemisphere was
cut into small pieces and treated with 0.1% trypsin solution
in Dulbecco’s phosphate buffered saline containing 0.15%
glucose (0.1% trypsin/DPBS/G) for 5 min at room temper-
ature. The cell pellets obtained by centrifugation at 1000
rpm for 5 min were cultured in F-10 medium containing
10% fetal calf serum (10% FCS/F-10) at 37 jC for 1 month
(primary culture of rat brain, M-PC). The cells were then
transferred to a 2.5-cm-diameter multiple tray for 1-week
secondary culture (M/W) after treatment with the 0.1%
trypsin/DPBS/G containing 1 mM ethylenediaminetetraace-
tic acid (EDTA) at 37 jC for 5 min, and then centrifuged to
obtain the cell pellets. Alternatively, astrocytes were pre-
pared by a conventional method of 1-week primary and
subsequent 1-week secondary cultures (W/W cells) [32].
2.2. Preparation of LDL containing 3H-cholesteryl ester
and labeling of astrocytes
LDL isolated by ultracentrifugation from fresh plasma of a
healthy volunteer was incubated with lipid microemulsion
containing [1,2-3H]cholesteryl oleate (Amersham) and a
plasma protein fraction of density > 1.25 g/ml, and the
labeled LDL was re-isolated by ultracentrifugation [33].
Astrocytes were washed three times with DPBS and incu-
bated with 25 Ag protein/ml of the labeled LDL in 0.02%
bovine serum albumin (BSA)/F-10 for 24 h, followed by
washing three times with DPBS. In order to examine the
uptake of LDL and the labeling of the cells, lipid was
extracted from the whole cells with hexane/isopropanol
(3:2, v/v) and analyzed by thin layer chromatography (TLC).
2.3. De novo syntheses of mevalonic acid and cholesterol
Rat astrocytes at a confluent cell density were washed
with DPBS four times and incubated in 0.1% BSA/F-10 for
24 h. To measure de novo syntheses of mevalonic acid and
cholesterol, the cells were incubated with [3H]acetate (20
ACi/ml, New England Nuclear) in a fresh 0.02% BSA/F-10.
The cholesterol synthesis was measured also by using [3H]
mevalonolactone (5 ACi/100 nmol/ml) for the down stream
of the step of hydroxymethylglutaryl-CoA (HMG-CoA)
reductase in the biosynthesis pathway. After the cells were
washed three times with cold DPBS, lipid was extracted
from the cells with hexane/isopropanol (3:2, v/v) and
analyzed by TLC for cholesterol biosynthesis measurement.
To detect mevalonic acid synthesis, the cells were rinsed
three times with cold DPBS, incubated with 0.25 N HCl at
37 jC for 15 min to allow lactonization of the [3H]meva-
lonic acid, scraped with a rubber policeman and sonicated.
The mevalonolactone was identified by TLC after extraction
from the cell suspension with chloroform/methanol (2:1, v/
v) [34].
2.4. HMG-CoA reductase assay
HMG-CoA reductase assay was carried out according to
the method described elsewhere [35]. The cells were har-
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vested by scraping with a rubber policeman and centrifuged
at 1000 g for 10 min. The cell pellet was treated with
buffer containing 50 mM of imidazole, 5 mM of EDTA, 200
mM of KCl and Brij 97, pH 7.4, at 37 jC for 10 min and
centrifuged at 12,000 g for 15 min. The aliquot of deter-
gent-solubilized extract was incubated with the buffer con-
taining 0.2 M of potassium phosphate, 40 mM of glucose 6-
phosphate, 5 mM of NADP, 8 mM of dithiothreitol, 20 unit/
ml of glucose 6-phosphate dehydrogenase and DL-3-[3-14C]-
hydroxy-3-methylglutaryl CoA (0.1 Ci/ml) at 37 jC for 2 h.
The reaction was terminated with 0.2 N HCl. The mixture
was incubated at 37 jC for 15 min to allow lactonization of
[14C]mevalonic acid. The labeled mevalonolactone was
identified by TLC by using acetone/benzene (1:1, v/v).
2.5. Analysis of cholesterol in the media
For standard measurement of cellular cholesterol release
[33], astrocytes were labeled by incubating with 25 Ag
protein/ml of the 3H-labeled LDL and the release of the
labeled free cholesterol into the medium was measured
during the incubation with the fresh medium for 8–24 h.
Alternatively, the cells were labeled with [3H]acetate (20–40
ACi/ml) for 12–24 h. After the cells were washed and
incubated in the fresh 0.02% BSA/F-10 for 12 h, the medium
was collected and centrifuged at 10,000 rpm for 1 h to
remove the cell debris. Lipid was extracted from the medium
and the whole cells separately with chloroform/methanol
(2:1, v/v) and hexane/isopropanol (3:2, v/v), respectively,
and analyzed by TLC to determine radioactivity of choles-
terol. The mass of free and total cholesterol in the cells and
media was determined by using enzymatic colorimetric
assay kits purchased from Wako and from Sigma Diagnos-
tics. Cholesterol ester was calculated by subtracting the
amount of free cholesterol from total cholesterol. Cellular
protein was measured by the method of Lowry using bovine
serum albumin as a standard [36]. Other specific modifica-
tions are described in the figure legends.
Fig. 1. Characterization of astrocytes after the primary culture of rat brain cells. (a) Growth curve of rat astrocytes. After 1-week (open circles) or 1-month
primary culture (open triangles) of rat fetal brain cells, the cells were seeded at a density of 3.4 104 cells/well on 2.5-cm culture plates and maintained in 10%
FCS/F-10 medium. Cell number was counted and the medium was replaced every 2 days. (b) Microscopic view of W/W and M/W cells—after 1-week
secondary culture following 1-week and 1-month primary culture, respectively. (c and d) Expression of cellular marker proteins in the astrocytes. The cells were
solubilized, and vimentin and GFAP was detected for W/W and M/W cells by immunoblotting analysis as described in Section 2. (e) Cholesterol content in
astrocytes. Lipid was extracted from W/W and M/W cells with hexane/isopropanol, and free and total cholesterol mass were determined by enzymatic methods
as described in Section 2. Cholesterol ester was calculated by subtracting free cholesterol from total cholesterol. ***: P< 0.01 from the 1-month primary culture
in panel (a); ** and ***: P< 0.05 and P< 0.01 from W/W cells in panel (e).
Table 1
Cellular population in the astrocyte preparations
GFAP-positive
(astrocytes)
MBP-positive
(oligodendroglias)
ED-1 antigen-positive
(microglias)
W/W 95.0F 3.3 0.27F 0.10 2.6F 1.6
M/W 95.3F 4.3 0.36F 0.21 3.1F 2.2
The data indicate percentage to the total cells of the cells positively
identified as astrocytes, oligodendroglia and microglia by immunostaining
with an anti-GFAP antibody, an anti-myelin basic protein (MBP) and a
monoclonal antibody against ED-1 that recognizes microglial antigen,
respectively. The values represent averageF S.E. of three samples.
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2.6. Analysis of lipoprotein produced by astrocytes
The astrocytes loaded with LDL (25 Ag of protein/ml) for
24 h in a 10-cm culture dish were incubated with a fresh
0.02% BSA/F-10 without LDL for 24 h after washing. The
medium (10 ml) was collected and cell debris was removed
by centrifugation at 10,000 rpm for 1 h. The density of the
medium was then adjusted to 1.20 g/ml with sucrose or the
medium was overlayered on the layers of 1.20 g/ml and 1.07
g/ml of sucrose solutions (7.5 ml each), followed by
centrifugation at 49,000 rpm for 48 h in a RP50T rotor
(HITACHI). The sample was recovered into 12 equal
fractions from the bottom. A 500 AL aliquot of each fraction
was used for immunoblotting after the precipitation by the
treatment with 10% trichloroacetic acid [9].
2.7. Analysis by western blotting
ForWestern blotting, the cells were treated with 2% Triton
X-100 solution containing 0.1 N NaOH/1 mM EDTA. After
the neutralization, the solubilized cell protein was subjected
to 0.5% SDS/12% polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to a Sequi-BlotTM PVDF Membrane
(Bio-Rad). For the analysis of the medium, the cells were
Fig. 2. Release of cholesterol and apoE, and apoE mRNA level in W/Wand M/W cells. (a) Cholesterol mass measurement. The cells were incubated with fresh
0.02% BSA/F-10 medium for 24 h. Lipid was extracted from the medium with chloroform/methanol, and cholesterol was measured by an enzymatic method.
(b) Radiolabeled cholesterol. The cellular cholesterol was labeled by incubating with LDL containing [3H]-cholesterol ester for 24 h, and the release of the
labeled cholesterol for 8 h was determined as described in the text. The uptake of LDL was estimated by incorporation of the radioactivity from LDL containing
the radiolabeled cholesteryl ester and same between W/W and M/W cells. Cholesterol release was calculated as a percentage of free cholesterol count in the
medium (esterified cholesterol in the medium was always negligible) against the total cholesterol count in the well (the total of free and esterified cholesterol in
the cell plus medium). For panels (a) and (b), the data represent the average and S.E. of the triplicate samples, and * and ** indicate P < 0.05 and P < 0.01 from
W/W cells. (c) Secretion of apoE by W/W and M/W cells. The cells at the confluent stage were incubated with LDL (25 mg of protein/ml) in 0.02% BSA/F-10
medium for 24 h, and then the release of apoE into the medium in the next 24 h was analyzed by Western blotting as described in Section 2. (d) Analysis of
apoE in the conditioned medium of rat astrocytes by ultracentrifugation at a density of 1.20 g/ml. The media of W/W and M/W cells were fractionated from the
bottom as described in Section 2. SDS-PAGE and Western blotting were carried out for each 12 fractions from the bottom to the top fraction after the 10%
trichloroacetate treatment. (e) Expression of apoE mRNA in W/Wand M/W cells. Total cellular RNA, 5 Ag, was subjected to reverse transcription for 10 min at
25 jC, for 50 min at 50 jC, and then for 15 min at 70 jC, and 0.5 Ag of cDNA product was amplified using apoE primer pairs (5V-
GCGCACCTCCTCCATCTCCTC as a sense and 5V-AGGATCTATGCAACCGACTCG as an antisense) [73] with 30 cycles as described in Section 2. The
PCR products for mRNA 356-747 were visualized as described in the text. The expression of the housekeeping gene h-actin was analyzed as a control.
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incubated with fresh 0.02% BSA/F-10 medium for 24 h and
the protein fraction of the medium was recovered as a pellet
precipitated by centrifugation at 15,000 rpm for 15 min in
10% trichloroacetic acid. The aliquot (93.5 Ag protein) of the
pellet was analyzed by SDS-PAGE (12% polyacrylamide gel)
and immunoblotting using a rabbit anti-rat apoE antibody.
The membrane was immunostained with a mouse anti-
vimentin monoclonal antibody (IF01, Oncogene Science,
Inc.), a rabbit anti-cow glial fibrillary acidic protein (GFAP)
antibody (Dakopatts) and a rabbit anti-rat apoE antibody, a
generous gift from Dr. Jean Vance (University of Alberta).
Density of apoE digital scanning by an image scanner (Epson
GT 9500 ART) and semi-quantified by Adobe Photoshop
was largely proportional to the amount of the protein when
the medium was diluted in series.
2.8. Reverse transcription-polymerase chain reaction (RT-
PCR)
Total cellular RNA was extracted from rat astrocytes by
ISOGEN (Wako Life Science), and reverse-transcribed to
cDNA using a Super Script Preamplification System (Gibco
BRL). The resulting cDNA was subjected to PCR by using
the DNA probes for rat apoE-mRNA, aFGF-mRNA, and
actin-mRNA. After the electrophoresis of the products,
agarose gel was stained with freshly prepared SYBR Gold
nucleic acid gel stain solution (Molecular Probes, Inc.). The
band was detected by a UV transilluminator, UVP NLM-20
E at 302 nm.
3. Results
3.1. Characterization of astrocytes
Fetal rat brain cells grown for 1 week or 1 month as a
primary culture were seeded at 3.4 104 cells/well in a 2.5-
cm-diameter multiple tray. The rate of cell growth and
confluent cell density were both higher in the cells after
1-week primary culture than in those after 1-month primary
culture (Fig. 1a). Since both reach the confluent stage at the
day 7 of the secondary culture, the cells in this stage were
used for further analysis as W/W and M/W cells, respec-
tively. Relative cellular population was estimated in these
two cell preparations by indirect immunohistochemical
staining by using specific antibodies against GFAP and
myelin basic protein and by an antibody ED-1 that recog-
nizes microglia antigen [37,38], for positive identification of
astrocytes, oligodendroglias and microglias, respectively.
The result was similar for both preparations with respect
to cellular composition (Table 1). Type-2 astrocyte-like cells
were identified at 5–15% of the population of M/W cells
Fig. 3. Syntheses of cholesterol and mevalonic acid in rat astrocytes. (a and b) W/W, M/Wand W/M cells were incubated with 20 ACi/ml of [3H]-acetate, or (c)
5 ACi/ml of [3H]-mevalonolactone in 0.02% BSA/F-10 for metabolic labeling of cholesterol in panels (a) and (c) and mevalonic acid in (b). Lipid was extracted
according to the method described in Section 2. (d) HMG-CoA reductase activity of rat astrocytes was measured by using a substrate DL-[3-14C] HMG-CoA as
described also in the text. Each data represents the average and standard error of the triplicate samples, and * and ** indicate P< 0.05 and P < 0.01 from the W/W,
respectively.
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but not in W/W cells (Fig. 1b), indicating that the cells
appeared to be activated. Neurons were hardly identified in
either preparation.
The vimentin expression was lower in M/W cells than in
W/W cells, and GFAP expression was higher in M/W cells
than in W/W cells (Fig. 1c and d), indicating differentiation
and/or activation of astrocytes during the long-time primary
culture, being consistent with the morphological finding. As
demonstrated in Fig. 1d, unesterified and esterified choles-
terol levels were both lower in M/W cells than in W/W cells.
3.2. Release and synthesis of cholesterol and apoE by
astrocytes
Cellular cholesterol release into the medium in 24 h was
higher in M/W cells than W/W cells (Fig. 2a and b). M/W
cells also secrete more apoE into the medium (Fig. 2c).
Ultracentrifugal analysis of the media at the solvent density
of 1.20 g/ml showed that most of apoE released from M/W
cells was recovered in the lipoprotein fraction floated to the
top (Fig. 2d), indicating that apoE is secreted to generate
HDL with cellular lipid as previously reported [9]. Message
of apoE markedly increased in M/W cells in comparison to
W/W cells when examined by RT-PCR (Fig. 2e). Thus, the
increased apoE biosynthesis and secretion appear to cause
M/W cells to release more cholesterol as lipoprotein, result-
ing in the decrease of cellular cholesterol.
Syntheses of mevalonic acid and cholesterol from
[3H]acetate were more active in M/W cells than W/W cells
(Fig. 3a and b) while cholesterol synthesis from mevalonate
was not significantly different between M/W and W/W cells
(Fig. 3c). The direct measurement of the HMG-CoA reduc-
tase activity showed that it was higher in M/W cells than W/
W cells (Fig. 3d). The results thus showed that cholesterol
biosynthesis in M/W cells was increased by upregulation of
HMG-CoA reductase activity, perhaps due to the active
HDL assembly by enhanced apoE synthesis and cholesterol
release.
3.3. Effects of the conditioned medium and cytokines
In order to investigate the mechanism for this change, we
examined involvement of a trophic factor(s) potentially
secreted into the medium during the long-term primary
culture of rat brain cells. The conditioned media of W/W
cells and the 2-week and 1-month primary cultures (W/W-
CM, 2W-CM and M-CM, respectively) were given to W/W
cells and incubated for 2 weeks. Cholesterol release from
W/W cells was increased by the pretreatment with M-CM
(Fig. 4a and b). ApoE secretion from W/W cells was also
stimulated by M-CM in the same manners (Fig. 4c and d).
The effect of 2W-CM was inconclusive by showing appa-
rent inconsistency between cholesterol release and apoE
secretion, presumably due to technical limitation. These
findings indicated that M-CM contains a trophic factor(s)
to stimulate W/W cells to increase the release of apoE and
Fig. 4. Stimulation of cholesterol release from astrocytes by the conditioned
medium of primary culture. (a) W/W cells were incubated for 2 weeks with
1 ml/2 ml of the conditioned medium prepared from the 2-week primary
culture or the 1-month primary culture of rat brain cells (2W-CM and M-
CM, respectively). The cells in the control experiment were incubated with
2 ml of 2% FCS/F-10 (control) or 1 ml/2 ml of the conditioned medium
from the W/W cells (W/W-CM). The replacement of the stimulants in fresh
0.02% BSA/F-10 was carried out at every 2 days. After the treatment, the
cells were washed with DPBS three times and cultured in 0.02% BSA/F-10
for 24 h. The cells were then incubated with 25 Ag protein/ml of [3H]-LDL
in fresh medium for 24 h, followed by washing, replacement with the fresh
medium and further 24-h incubation and then the release of the labeled
cholesterol into the medium was analyzed. (b) The cells were incubated
with M-CM (0.5 ml/ml) for the indicated time period. After washing and
replacement with fresh 0.02% BSA/F-10, the cells were incubated with 40
ACi/ml of [3H]-acetate for 12 h and washed three times. The cells were
incubated for 12 h in the fresh 0.02% BSA/F-10 medium containing 1 mM
acetate and release of the radioactive cholesterol in the medium was
determined after separation by TLC. Cholesterol release was calculated as a
percentage of free cholesterol in the medium against the free cholesterol
radioactivity of the sum of the cell and medium, and * indicates P < 0.05
from control in panel (a). The release of cholesterol was shown by the same
percentage and by the free cholesterol count released into the medium per
cell protein, and ** and ## indicate P < 0.01 from control in the panel (b).
The data represent the average and S.E. of the triplicate samples in the both
panels. (c) Stimulation of apoE secretion from rat astrocytes by the
conditioned medium of rat brain primary culture. W/W cells were incubated
for 2 weeks with 2W-CM, M-CM or 2% FCS/F-10 as described in Fig. 2c.
The astrocytes were washed with DPBS for four times and cultured in
0.02% BSA/F-10 for 24 h. The cells were washed again and further
incubated for 24 h in the fresh 0.02% BSA/F-10 medium, and apoE in the
medium was analyzed by Western blotting. The data represent one of the
three experiments that all gave similar results, and the digital scanning
indicated relative density of the apoE bands 1:2.4:3.2 for C/2W/M. (d) The
medium was recovered from the 24-h cultured W/W cells after the
stimulation by M-CM for the indicated period of time and washing, and
apoE in the medium was analyzed by Western blotting.
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cholesterol. The astrocytes appeared to be activated after the
stimulation based on their morphological change.
We searched potential trophic factor(s) contained in M-
CM to increase both apoE secretion and cholesterol release
among several candidates that reportedly function in the
brain (Fig. 5). Fig. 5a shows that among the examined
trophic factors, aFGF, basic FGF, insulin-like growth factor
1, interleukin-1h and insulin, only aFGF enhanced the
cholesterol release (Fig. 5a and b). Acidic FGF also
increased syntheses of cholesterol and mevalonate in a
dose-dependent manner (Fig. 5c and d). ApoE secretion
by W/W cells and the message of apoE in W/W cells were
both increased by aFGF (Fig. 5e and f). ApoE and choles-
terol formed simultaneous peaks in density gradient analysis
of the medium with and without stimulation by aFGF (Fig.
6), showing that aFGF increased the generation of HDL in
the medium. Morphological evidence also indicated that the
cells are activated by aFGF (data not shown). Thus, aFGF
Fig. 5. Effect of growth factors on the synthesis and release of cholesterol of W/W cells. (a) After incubation in 0.02% BSA/F-10 for 24 h, W/W cells were
treated with various growth factors such as aFGF, basic(b)FGF, insulin-like growth factor (IGF)-I, interleukin-1h (IL-1B), or insulin (each 100 ng/ml) for 24 h.
After washing, the cells were labeled with 40 ACi/ml of [3H]-acetate for another 12 h in the presence of each growth factors. The cells were washed and
incubated for 8 h in the fresh medium containing 1 mM acetate and each growth factor. Lipid was extracted from the medium and cells and radioactivity in free
cholesterol was analyzed by TLC. The results are expressed in both the percentage of the released cholesterol to the total well cholesterol (a-1) and the count of
cholesterol per cell protein (a-2). (b) W/W cells were incubated with 100 ng/ml of aFGF for 0, 8 or 24 h, and labeled with 40 ACi/ml of [3H]-acetate for 12 h
after washing. The release of the labeled free cholesterol into the medium was determined for 12-h incubation in a fresh medium in the presence of 1 mM
acetate. The results are shown in the two different ways again. (c and d) W/W cells were incubated with aFGF at the indicated concentration in 0.02% BSA/F-
10 medium for 24 h and incubated with 20 ACi of [3H]-acetate for 3 h in the fresh medium. The newly synthesized cholesterol (c) and mevalonic acid (d) in the
cells were detected by counting radioactivity in each compound. Each data represents the average and standard error of the triplicate experiments, and ** and
*** indicate P< 0.05 and P < 0.01 from control or time zero. Single asterisks in panels (b) and (d) indicate P= 0.056 and P= 0.051, respectively. (e)
Stimulation of apoE secretion from W/W cells by aFGF and by the conditioned medium. W/W cells were incubated in 0.02% BSA/F-10 containing 50 ng/ml of
aFGF for the indicated period of time. The cells were washed and incubated for further 24 h in the fresh medium, and the conditioned medium was used for
immunoblotting analysis. The data represent one of the three experiments that all gave similar results, and the digital scanning indicated relative density of the
apoE bands 1.0:1.3:1.7:2.0 for 0:2:12:24. (f) Messenger RNA in W/W cells treated with 100 ng/ml aFGF for 24 h. The experimental condition was the same as
Fig. 2e.
S. Ueno et al. / Biochimica et Biophysica Acta 1589 (2002) 261–272 267
reproduced the effect of M-CM on W/W cells with respect
to the increase of apoE biosynthesis and its release, and of
the release and biosynthesis of cholesterol.
The M-CM was pretreated with an anti-aFGF antibody
immobilized on Protein G-Sepharose in order to examine
whether the stimulating effect of M-CM is related aFGF. The
treatmentresultedinthecompletelossoftheactivityofM-CMto
stimulateW/Wcells to increaseof thereleaseofcholesteroland
Fig. 6. DensitygradientultracentrifugationanalysisoftheculturemediumofW/
Wcells treatedwith aFGF.Afterwashingandpreincubation in 0.1%BSA/F10
for 24h,W/Wcells in fresh 0.02%BSA/F10mediumwere incubatedwith and
without100ng/mlofaFGFfor24h.Theculturemediumwasanalyzedbydensity
gradientultracentrifugationbetween thedensitiesasdescribed in the text.Each
tube was fractionated from the bottom into 11 fractions. Cholesterol was
measured by enzymatic colorimetric assay and apoEwas analyzedbyusing an
immunoblotting technique foreachfraction.Lineswithoutsymbol indicate the
density of each fraction.
Fig. 8. Expression of aFGF mRNA in the rat brain cells of the 1-month-
primary culture (M-PC). Total cellular RNAwas extracted from the cells of
M-PC and W/W cells as described in the text. RT-PCR was carried out by
using aFGF primer pairs (5V-AAGCCCGTCGGTGTCCATGG and 5V-
GATGGCACAGTGGATGGGAC) [74] with 30 cycles according to the
methods as described in Fig. 2.
Fig. 7. Inhibition by an anti-aFGF antibody of the enhancement of cholesterol release and apoE secretion by the conditioned medium of the 1-month primary
culture (M-CM). (a and b) The M-CM was treated with a goat anti-human aFGF antibody (Santa Cruz Biotech., Inc.) or a rabbit anti-rat apoE antibody
conjugated on protein G-Sepharose (Amersham Pharmacia Biotech.) for 4 h at room temperature, and the gels were removed by centrifugation. W/W cells were
incubated for 5 days with 0.5 ml/ml of M-CM, the medium pretreated by either antibody or 0.02% BSA/F-10 as a control. The cells were labeled with 30 ACi/
ml of [3H]-acetate for 12 h, washed three times with DPBS and incubated in 0.02% BSA/F-10 containing 1 mM acetate for further 12 h. The release of newly
synthesized cholesterol into the medium was determined by counting the radioactivity in cholesterol. The results were expressed as percentage to total free
cholesterol count in the well and as the count per cell protein. Each data represents the average and standard error of the triplicate experiments, and ** and ***
indicate P < 0.05 and P< 0.01 from control in the panels. (c) Stimulation of apoE secretion from W/W cells by M-CM, and its inhibition by an anti-aFGF
antibody. W/W cells were incubated for 5 days in the fresh 0.02% BSA/F-10 medium containing the indicated conditioned medium. The cells were washed and
incubated for further 24 h, and the conditioned media was analyzed by immunoblotting. The data represent one of the three independent experiments.
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apoE(Fig.7aandb).ExpressionofaFGFmRNAwasapparentin
the cells after 1-monthprimaryculturebyRT-PCRwhile itwas
veryfaintinW/Wcells(Fig.8).
We thus concluded that an aFGF-like trophic factor(s)
was released into the medium of the 1-month primary
culture of rat brain cells and enhanced biosynthesis and
secretion of apoE, release of cellular cholesterol, and per-
haps subsequent decrease of cellular cholesterol level and
increase of cholesterol biosynthesis, in rat astrocytes.
4. Discussion
Regulation of biosynthesis and secretion of apoE and
generation of HDL particles with cellular lipid in the brain is
one of the key factors for cholesterol homeostasis in the
CNS, and plays an important role especially in development
and recovery from injury [18] though it may not be an
absolute requirement [6,17,39,40]. We investigated the
mechanism for this regulation in astrocytes, a major site
of the synthesis of apoE and generation of HDL. We
focused on searching a potential trophic factor(s) involved
in regulation of syntheses and secretion of apoE and HDL,
by employing extended primary culture of the brain cells
that might lead to a different stage of differentiation/activa-
tion of astrocytes. The findings are summarized as follows:
(1) apoE biosynthesis, its secretion as HDL with cellular
cholesterol and cholesterol biosynthesis were all increased
in the astrocytes prepared after a month-long primary
culture of rat brain cells (M/W cells) in comparison to the
cells prepared by conventional 1-week primary and 1-week
secondary cultures (W/W cells), and consequently, cellular
cholesterol in M/W cells was found to decrease; (2) the
conditioned medium of the 1-month-long primary culture
(M-CM) stimulated W/W cells to gain the same properties
of M/W cells with respect to the apoE and cholesterol
metabolism; (3) aFGF stimulated W/W cells in the same
manner as M-CM did, and the treatment of the medium with
an anti-aFGF antibody abolished its stimulatory effects.
Decrease of vimentin, increase of GFAP and an appear-
ance of type-2 astrocyte-like cells were observed in M/W
cells. Vimentin decreases and GFAP increases in the brain
during the CNS development [41]. In cultured astrocytes,
glia maturation factor and cAMP increased GFAP and type-
2 astrocytes [42,43]. Thus, low vimentin level and high
GFAP level in M/W cells indicate activation or maturation
of astrocytes during the long time primary culture. The
factors secreted into the medium during this activation/
maturation was examined with respect to stimulation of
synthesis and secretion of apoE and cholesterol, in order to
investigate whether an extracellular factor is involved in this
change. M-CM was shown to induce the increase of these
reactions in W/W cells. The results thus strongly indicated
that the increase of apoE-HDL release by astrocyte after a
long primary culture is a result of a process that involves
stimulation of the cells by a trophic factor(s) released by the
brain cells. The factor was identified as an aFGF-like
factor(s) by the fact that stimulatory effects of M-CM were
reproduced by aFGF and removed by an anti-aFGF anti-
body. Expression of aFGF mRNA was demonstrated in the
cells after the 1-month primary culture by RT-PCR. There-
fore, we conclude that an aFGF-like trophic factor(s),
presumably produced and released into the medium during
the primary culture of the brain cells, is responsible for
stimulation of apoE synthesis, HDL generation and subse-
quent changes in cholesterol homeostasis in the astrocytes.
Several cytokines have been examined for the effect on
astrocytes in terms of the secretion of apoE [44]. Epidermal
growth factor reportedly increased apoE secretion by human
astrocytes of high passage, whereas interleukin 1a and 1h,
interferon g, and basic FGF did not. Acidic FGF, a heparin-
binding growth factor 1, is known as a potent mitogen for
normal and transformed glial cells, and induces the mor-
phological differentiation of these astroglial cells [45–49].
It has been thought that aFGF is primarily produced in
neurons in vivo [50–55], but astrocytes are also identified
as its potential source [56–59]. We have not yet determined
which cell produces aFGF-like trophic factor in the long-
term primary culture of fetal rat brain cells. However,
neurons almost disappear during the initial 2 weeks of the
primary culture and were hardly identified both in W/W and
in M/W cells (Table 1). Therefore, it is likely that aFGF
produced and released by astrocytes acts in an autocrine
manner to stimulate apoE synthesis and HDL production.
Function of apoE and apoE-HDL in the CNS has not
been fully understood. Many reports indicated the impor-
tance of this system in recovery from the injury of the nerve
system by showing the increase of the production and
secretion of apoE during and after the nerve degeneration
in the CNS or in chronic degenerative disease of the brain
[3,11,13–18]. Such a condition may cause astrocytes to
produce and release aFGF to result in autocrine stimulation
of apoE biosynthesis. The lipoprotein may be used as a
cholesterol carrier to support neurite outgrowth stimulated
by nerve growth factor [60]. The findings that aFGF
enhanced production and secretion of nerve growth factor
by astrocytes is consistent with this hypothesis [61–63].
Acidic FGF stimulates p21ras/Erk signaling pathway in rat
astrocytes [64], so that it at least acts through the membrane
receptors, and less likely through FGF receptor 1 ,which is
reportedly present predominantly in nuclei [65].
Injury of neurites induced expression of aFGF also in
neurites and Schwann cells in vitro [66]. Acidic FGF
appears to be highly expressed in neurons surviving in
Alzheimer’s disease [67], and is immunologically detected
in the neurons of rat brain after experimental cerebral
infarction [68]. Therefore, aFGF may also act as a paracrine
cytokine released also from neurons to stimulate astrocytes.
Interestingly, aFGF does not have a signal sequence so
that it is unlikely to be secreted by a regular secretory
pathway [69,70]. Some specific mechanisms may therefore
be required for the release of this cytokine such as an
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increase of the membrane permeability or simple disruption
of the membrane [71,72]. Although the astrocytes are most
likely to release aFGF in the current experimental system, it
is still important to identify which cells produce aFGF during
the long-term primary culture of fetal rat brain cells and how
it is released into the medium, in order to understand the
mechanism for cholesterol homeostasis in the CNS. Physio-
logical relevance of the current findings remains to be
confirmed by demonstrating the parallel observations in
vivo, such as the increase of aFGF in astrocytes in the brain
after certain types of stress or injury. Our preliminary results
indicate the post-injury increase of aFGF in astrocytes in the
region of the mouse brain. Investigations are currently
ongoing to answer these questions.
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